Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs—A Promising Approach to Fight Cancer Drug Resistance

Malignant diseases present a serious public health burden and their treatment with traditional chemotherapy cannot be considered an all-round solution, due to toxic side effects. Selenium compounds (Se-compounds) have received substantial attention in medicinal chemistry, especially in experimental...

Descripción completa

Detalles Bibliográficos
Autores principales: Spengler, Gabriella, Gajdács, Márió, Marć, Małgorzata Anna, Domínguez-Álvarez, Enrique, Sanmartín, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359065/
https://www.ncbi.nlm.nih.gov/pubmed/30669343
http://dx.doi.org/10.3390/molecules24020336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359065/
https://www.ncbi.nlm.nih.gov/pubmed/30669343
http://dx.doi.org/10.3390/molecules24020336

Ejemplares similares